(Press-News.org) MANHATTAN -- Kansas State University researchers are defeating persistent bacteria known for causing infections in hospitals.
The bacteria, Enterococcus faecalis, are the second-leading cause of hospital-associated infections in the U.S., said Lynn Hancock, associate professor of biology and leader of the research. His team has discovered how a regulatory system helps this bacteria resist a host's innate immune defense -- a finding that may help develop novel drug compounds to fight the bacteria.
"Right now, we have very limited therapeutic interventions because the bacteria is highly resistant to not only antibiotics but a variety of other environmental stresses," Hancock said. "With the diminishing number of antibiotics that are effective at treating these types of infections, we need to come up with new strategies."
Enterococcus faecalis, or E. faecalis, is naturally found in the gastrointestinal tract of humans and other mammals. But outside the intestinal walls, the bacteria can cause bacteremia, urinary tract infections and endocarditis.
An added obstacle is that the bacteria are 100 to 1,000 times more resistant to lysozyme than other bacteria, Hancock said. Lysozyme is an infection-fighting substance that humans produce and is found in numerous body tissues, such as tear film, the urinary tract and saliva. The regulatory system of E. faecalis also makes it very resistant to other cellular stresses -- such as elevated temperature, low pH and oxidative stress -- that are part of a person's innate immune defense and help fight infection.
"Enterococcus has evolved sensing systems to find out the kind of environment it is in," said Sriram Varahan, doctoral student in microbiology and member of Hancock's research team. "It is a really rugged bacteria that is known to persist and survive in environments where other pathogens are unable to do so. Many infectious disease specialists have given it the moniker of being the cockroach of the microbial world."
By understanding the bacteria's regulatory network, the researchers hope to develop novel drug compounds that can block the bacterium's ability to sense and respond to the presence of lysozyme and other stresses during infection. To find the bacteria's weakness, the scientists focused on a protein called Eep. While studies have shown that Eep is important during infection, the Kansas State University researchers discovered how Eep contributes to an important stress response that the bacteria use to survive the host defense.
It is an important finding because now researchers can develop compounds that inhibit the Eep protein, which makes the bacteria susceptible to lysozyme and stops infection. When humans produce lysozyme to fight the bacteria, the bacteria will be unable to fight back.
"It's kind of like hitting it in the Achilles' heel," Hancock said. "Then it is very much compromised to establish infection."
While the bacteria are still able to live without the Eep protein, the bacteria need it to cause infection, Hancock said. Studies have shown that when the Eep is inactivated, bacteria are compromised nearly 10,000-fold in their ability to cause infection.
"The ability to interfere with a bacteria's ability to establish infection is going to become a more popular theme for treating infections rather than simply killing the bacteria," Hancock said. "When you put selective pressure on bacterial populations to live or die, they are really good at circumventing the drugs and getting around the killing mechanism."
For future research, Hancock and his team want to find what compounds are most effective at interfering with Eep to make the bacteria susceptible to lysozyme. They also want to study the SigV protein, which coordinates expression of target genes that are controlled by the Eep protein. Similar to Eep, if SigV is inactivated, then the target genes are not expressed and the bacteria do not become resistant to lysozyme. These target genes and proteins may also lead to new drug development possibilities.
"In the dawn of the post-antibiotic era, I think it is essential for us to have more options, rather than depending on a few silver bullets that are seemingly failing a lot in hospitals nowadays," Varahan said. "We have come up with new targets and hopefully they will work."
INFORMATION:
The scientists recently published their research in the Journal of Bacteriology. The research was part of a $1.5 million five-year grant from the National Institutes of Health.
Other researchers involved include Vijayalakshmi Iyer, research associate in biology, and William Moore, a former doctoral student in microbiology.
Researchers target the Achilles' heel of bacteria behind hospital-associated infections
2013-07-17
ELSE PRESS RELEASES FROM THIS DATE:
A heart of gold
2013-07-17
Heart tissue sustains irreparable damage in the wake of a heart attack. Because cells in the heart cannot multiply and the cardiac muscle contains few stem cells, the tissue is unable to repair itself — it becomes fibrotic and cannot contract properly.
In their search for innovative methods to restore heart function, scientists have been exploring cardiac "patches" that could be transplanted into the body to replace damaged heart tissue. Now, in his Tissue Engineering and Regenerative Medicine Laboratory, Dr. Tal Dvir and his PhD student Michal Shevach of Tel Aviv University's ...
Maize trade disruption could have global ramifications
2013-07-17
EAST LANSING, Mich. -- Disruptions to U.S. exports of maize (corn) could pose food security risks for many U.S. trade partners due to the lack of trade among other producing and importing nations, says a Michigan State University study.
The study, featured in the journal Risk Analysis, didn't primarily focus on plant disease, population growth, climate change or the diversion of corn to nonfood uses such as ethanol. It suggests, however, that significant stresses in these areas could jeopardize food security.
This is particularly true in nations like Mexico, Japan and ...
How rice twice became a crop and twice became a weed -- and what it means for the future
2013-07-17
The evolutionary biologist Stephen Jay Gould once asked whether the living world would be different "if the tape were played twice." If there were a duplicate Earth evolving quietly beside ours, would we observe the emergence of creatures like ourselves and of plants and anaimals familiar to us, or would the cast of characters be entirely different?
It's an intriguing question.
So far replicate Earths are in short supply, but cases of parallel evolution (the same trait evolving independently in related lineages) allow scientists to ask some of the same questsions.
One ...
BPA + chlorine = bad news
2013-07-17
For years, scientists have been worried about bisphenol A. The chemical is known as an "endocrine disruptor," a substance that interferes with the body's hormone signaling system, and it's found in everything from plastic drink bottles to the linings of food and drink cans to the thermal paper used for cash register receipts — not to mention the urine of 92.6 percent of Americans over the age of six. BPA has been associated with the development of chronic diseases such as diabetes, asthma and ovarian dysfunction. In 2012, the FDA banned BPA from use in the production of ...
Frontiers news briefs: July 16
2013-07-17
Frontiers in Human Neuroscience
Drinking water can boost cognitive performance
There is evidence that mild dehydration has a negative effect on the brain's performance. Caroline Edmonds and colleagues from the University of East London and the University of Westminster here report that drinking water can improve performance on tasks that require a rapid response, particularly when thirsty. They tested 34 adults, who had not eaten or drunk anything overnight, for memory, attention, learning, and reaction time. Subjects were tested on two mornings: once after they had ...
The global burden of sickle cell anemia in young children is increasing
2013-07-17
The global burden of sickle cell anemia (SCA), a hereditary blood disorder, is increasing, with almost half a million babies estimated to be born with the condition in 2050, according to a study published in this week's PLOS Medicine. The study, conducted by Frédéric Piel and colleagues from the University of Oxford and Imperial College in the United Kingdom, and the KEMRI/Wellcome Trust Research Programme, Kenya, suggests that implementing basic health interventions could significantly reduce death rates in children aged less than 5 years with the condition. These findings ...
Improving systematic reviews of animal studies will help translational medicine
2013-07-17
Many new developments and initiatives have been introduced to improve the quality and translational value of animal research, and must continue with support from the wider scientific community. These are the conclusions of a new article in PLOS Medicine this week by Carlijn Hooijmans and colleagues from the Radboud University Nijmegen Medical Centre, Netherlands, who summarize these new developments.
Focusing on the quality of study conduct, reporting, and replication; systematic reviews and meta-analyses; and study registration, publication bias, and data sharing, the ...
Potential neurological treatments often advance to clinical trials on shaky evidence, study says
2013-07-17
STANFORD, Calif. - Clinical trials of drug treatments for neurological diseases such as Alzheimer's and Parkinson's often fail because the animal studies that preceded them were poorly designed or biased in their interpretation, according to a new study from an international team of researchers. More stringent requirements are needed to assess the significance of animal studies before testing the treatments in human patients, the researchers say.
The team - led by John Ioannidis, MD, DSc, a professor of medicine at the Stanford University School of Medicine and an expert ...
Bias pervades the scientific reporting of animal studies
2013-07-17
A new study published in the open access journal PLOS Biology suggests that the scientific literature could be compromised by substantial bias in the reporting of animal studies, and may be giving a misleading picture of the chances that potential treatments could work in humans.
Testing a new therapeutic intervention (such as a drug or surgical procedure) on human subjects is expensive, risky and ethically complex, so the vast majority are first tested on animals. Unfortunately, cost and ethical issues constrain the size of animal studies, giving them limited statistical ...
6 steps could cut heart failure readmissions
2013-07-17
There are six procedural things hospital teams can do to help heart failure patients avoid another hospital stay in the 30 days after they're discharged — and if all six are followed, patients are even more likely to avoid readmission, according to new research in the American Heart Association's journal Circulation: Cardiovascular Quality and Outcomes.
Each step alone had some impact, but researchers discovered that if all six recommendations are followed, readmissions could drop as much as 2 percent. The study's lead author said that may seem like a small number, but ...